
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.650 | 1.650 | 0.000 |
Shares | 98.350 | 98.350 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.701 | 15.998 |
Price to Book | 1.784 | 1.652 |
Price to Sales | 1.688 | 1.120 |
Price to Cash Flow | 11.686 | 9.396 |
Dividend Yield | 2.594 | 2.351 |
5 Years Earnings Growth | 5.077 | 10.328 |
Name | Net % | Category Average |
---|---|---|
Consumer Defensive | 45.460 | 9.878 |
Healthcare | 20.050 | 8.864 |
Communication Services | 14.120 | 7.286 |
Technology | 12.470 | 15.974 |
Financial Services | 4.990 | 11.253 |
Consumer Cyclical | 2.910 | 15.251 |
Number of long holdings: 22
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Obic Business Consultants | JP3173500004 | 9.55 | 8,562.0 | +2.31% | |
Kao Corp. | JP3205800000 | 9.42 | 6,704.0 | -0.49% | |
Nintendo | JP3756600007 | 9.19 | 13,310.0 | -0.89% | |
Astellas Pharma Inc. | JP3942400007 | 6.42 | 1,620.0 | 0.00% | |
Sysmex Cor | JP3351100007 | 5.37 | 1,868.0 | -1.32% | |
Milbon Co Ltd | JP3910650005 | 4.83 | 2,498.0 | +0.12% | |
Calbee Inc | JP3220580009 | 4.78 | 2,675.5 | -1.35% | |
Mandom Corp | JP3879400004 | 4.72 | 1,420.0 | -0.56% | |
Square Enix Holdings Co Ltd | JP3164630000 | 4.69 | 10,135.0 | -0.30% | |
Takeda Pharmaceutical | JP3463000004 | 4.59 | 4,421.0 | -0.23% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Lindsell Train Global Equity Fund D | 3.79B | -1.93 | 5.66 | 10.61 | ||
Lindsell Train Global Equity Fund A | 3.61B | 0.21 | 5.67 | 9.91 | ||
Lindsell Train Global Equity Fund B | 3.61B | 0.22 | 6.00 | 10.39 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review